Anti-amyloid antibodies lecanemab and donanemab are in clinical use now, but that does not mean research on them has stopped. At the Clinical Trials on Alzheimer’s Disease conference, held October ...
Significant year-to-year fluctuations in cholesterol levels without changes in medication may indicate that older adults have a higher risk for cognitive decline or dementia, according to preliminary ...